Vise Technologies Inc. Buys New Shares in Cigna Group $CI

Key Points

• Vise Technologies initiated a Cigna position by purchasing 18,091 shares valued at approximately $4.99 million. Other institutional investors also increased their holdings, with institutions and hedge funds owning 86.99% of the stock.
• Cigna reported quarterly EPS of $7.78, exceeding analyst expectations of $7.60, while revenue reached $70.04 billion, up 6.7% year over year. The company reaffirmed fiscal 2026 EPS guidance of approximately $30.45.
• Cigna declared a quarterly dividend of $1.56, equivalent to $6.24 annually and a 2.3% yield. Analysts maintain a “Moderate Buy” consensus, with an average price target of $339.45 versus the stock’s reported $274.50 price.

Vise Technologies Inc. bought a new position in shares of Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 18,091 shares of the health services provider's stock, valued at approximately $4,987,000.

Other large investors have also recently bought and sold shares of the company. Assetmark Inc. raised its position in Cigna Group by 10.0% during the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider's stock worth $17,515,000 after acquiring an additional 5,963 shares in the last quarter. HighTower Advisors LLC lifted its stake in Cigna Group by 402.7% in the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider's stock valued at $97,701,000 after acquiring an additional 283,897 shares during the last quarter. Handelsbanken Fonder AB grew its position in shares of Cigna Group by 12.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider's stock valued at $22,833,000 after acquiring an additional 8,960 shares during the period. Victory Capital Management Inc. increased its stake in shares of Cigna Group by 41.1% during the 4th quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider's stock worth $371,206,000 after purchasing an additional 392,978 shares during the last quarter. Finally, TD Asset Management Inc increased its stake in shares of Cigna Group by 4.8% during the 2nd quarter. TD Asset Management Inc now owns 249,966 shares of the health services provider's stock worth $68,911,000 after purchasing an additional 11,471 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of CI stock opened at $274.50 on Friday. The company has a market capitalization of $72.53 billion, a price-to-earnings ratio of 11.36, a PEG ratio of 0.95 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The company has a 50-day simple moving average of $284.63 and a 200 day simple moving average of $281.41. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business's revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, sell-side analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group's dividend payout ratio is presently 25.82%.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the company's stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on CI. Guggenheim raised their target price on shares of Cigna Group from $338.00 to $361.00 and gave the company a "buy" rating in a research note on Friday, July 31st. Robert W. Baird set a $362.00 price target on Cigna Group in a research report on Friday, July 31st. The Goldman Sachs Group upped their price objective on Cigna Group from $335.00 to $340.00 and gave the company a "buy" rating in a research note on Monday, May 4th. UBS Group raised their price objective on Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, May 22nd. Finally, Wolfe Research reissued an "outperform" rating and set a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source